COMMUNIQUÉS West-GlobeNewswire

-
Merus annonce l’acceptation par la FDA américaine et l’examen prioritaire de la demande de licence de produit biologique relative à Zeno dans le traitement du CPNPC et de l’ACP NRG1+
07/05/2024 -
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
07/05/2024 -
Avid Bioservices to Participate at Upcoming Investor Conferences
07/05/2024 -
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07/05/2024 -
Oculis Publishes Invitation to the Annual General Meeting
07/05/2024 -
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07/05/2024 -
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
07/05/2024 -
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
07/05/2024 -
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
07/05/2024 -
ICU Medical Announces First Quarter 2024 Results
07/05/2024 -
Ocular Therapeutix™ Reports First Quarter 2024 Results
07/05/2024 -
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
07/05/2024 -
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
07/05/2024 -
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
07/05/2024 -
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
07/05/2024 -
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
07/05/2024 -
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
07/05/2024 -
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability
07/05/2024 -
ResMed Announces Participation in the RBCCM Global Healthcare Conference
07/05/2024
Pages